Pharmafile Logo

News and Press Releases

Acuitas Therapeutics to Showcase LNP Delivery Platform at Four Prestigious Conferences in November 2025

29 October 2025 -- British Columbia, Canada -- Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, today announced its participation in four upcoming conferences in November 2025....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 11, 2025

Acuitas Therapeutics
info@acuitastx.com
6190 Agronomy Road, Suite 205. Vancouver, BC V6T 1Z3

Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate

Immune response successfully improved with second generation vaccine candidate4 November 2025 -- Saint-Herblain, France -- Valneva SE, a specialty vaccine company, today announced positive results of its Phase 1 clinical...

Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: November 4, 2025

Valneva
communications@valneva.com
6 rue Alain Bombard, 44800 Saint-Herblain, France

Naobios and Tokyo Metropolitan Institute of Medical Science partner to develop new live-attenuated vaccine against mpox

 Partnership aims to commercialize new mpox vaccine - with higher level of safety - by 2027 23 October 2025 -- Nantes, France, and Tokyo, Japan -- Naobios, a CDMO (Contract Development...

Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 23, 2025

Naobios
Operating office 6 rue Alain Bombard 44800 Saint-Herblain

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three...

Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 15, 2025

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa

Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV 10 October 2025 -- Cairo, Egypt; Berlin, Germany; and New York, New York -- IAVI,...

Category: Biotechnology, Drug Delivery, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 10, 2025

ProBioGen
info@probiogen.de
Herbert-Bayer-Straße 8 13086 Berlin

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

50 mg dose of once-daily obefazimod achieved clinically meaningful improvements, across all endpoints, regardless of prior inadequate response to advanced therapies (AT-IR) 50mg dose demonstrated clinically meaningful improvements in clinical...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 6, 2025

Abivax
info@abivax.com
7-11 Boulevard Haussmann 75009 Paris

Evonik and Ethris enter strategic partnership to expand offerings for nucleic acid delivery

Developing and manufacturing innovative LNP delivery technology for respiratory medicine and beyond Expanding Evonik’s CDMO offerings, enabling efficient translation from concept to clinic Accelerating RNA-based therapeutic solutions for customers through...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: September 9, 2025

Ethris
https://www.ethris.com/

Bavarian Nordic launches VIMKUNYA in the UK for the Prevention of Chikungunya, for individuals aged 12 years and older

3 September 2025 -- London, UK -- Bavarian Nordic A/S announced today the official UK launch of the VIMKUNYA® chikungunya vaccine (recombinant, absorbed). This follows the recent approval by the...

Category: Drug Discovery, Other, Pharmaceutical
Posted: September 3, 2025

Bavarian Nordic
info@bavarian-nordic.com
Bavarian Nordic GmbH Fraunhoferstrasse 13 D-82152 Martinsried

Moderna’s UK Manufacturing Facility Receives Manufacturing Licence from the MHRA

Milestone marks a pivotal step toward producing mRNA vaccines in the UK in 2025 15 April 2025 – London, UK – ACCESS WIRE – Moderna, Inc. (NASDAQ: MRNA) today announced...

Category: Manufacturing and Packing
Posted: April 15, 2025

Moderna
info@modernatx.com
Global Headquarters 200 Technology Square Cambridge, MA 02139

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

Eight participants achieved HBsAg loss at any time Two participants met criteria for functional cure Two participants who discontinued NUC therapy seroconverted to HBsAb positivity. 15 November 2024 -- Oxford,...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: November 15, 2024

Barinthus Biotherapeutics
Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2

Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval 22 August 2024 -- Massachusetts, US -- Moderna, Inc today...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 22, 2024

Moderna
info@modernatx.com
Global Headquarters 200 Technology Square Cambridge, MA 02139

Valneva Scotland Receives Prestigious Award for Health and Safety Excellence

8 August 2024 -- Scotland, UK -- Scotland's largest vaccine producer, Valneva Scotland Ltd, based in Livingston, has achieved an esteemed Silver Award for health and safety from the Royal...

Category: BioManufacturing, Pharmaceutical
Posted: August 9, 2024

Valneva
communications@valneva.com
6 rue Alain Bombard, 44800 Saint-Herblain, France

Europe 2024 World Vaccine Congress

23 July 2024, Barcelona, Spain – World Vaccine Congress Europe will host 3000+ attendees, 280 speakers, 150+ exhibitors and plenty of start-ups over the course of 4 days. With a...

Category: Drug Delivery, Other
Posted: July 23, 2024

World Vaccine Congress Europe
tayyab.abbasi@terrapinn.com
Barcelona

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics

June 17 2024 - California, US – Primrose Bio, Inc. (“Primrose,” the “company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in...

Category: Biotechnology, Drug Delivery, Other
Posted: June 18, 2024

Primrose Bio
media@primrosebio.com
Primrose Bio, 10790 Roselle Street, San Diego, CA 92121 United States

ModeX Therapeutics Leverages ProBioGen’s Expertise for Accelerated COVID-19 Antibody Development

29 May 2024 -- Berlin, Germany -- ProBioGen, a leading contract development and manufacturing organisation (CDMO), known for its innovative solutions in cell engineering and bioprocessing excellence, announces a pivotal...

Category: BioManufacturing, Biotechnology, Pharmaceutical
Posted: May 29, 2024

ModeX Therapeutics
info@modextx.com
20 Riverside Road Weston, MA 02493